June 2026– date –
-
Genomics Launches AI Platform ‘Mystra AI’ to Streamline Drug Discovery and Validation, with Anticipated Ripple Effects on Biomanufacturing Optimization
Biology Digital UK Overview Biotechnology firm Genomics officially launched 'Mystra AI,' an AI platform designed to significantly streamline drug discovery and validation processes. Built upon advanced machine learning models trained on ... -
Orchestrating the Next Era of Decentralized and Automated Bioprocessing: 75% Efficiency Boost in AAV Manufacturing and QC Modernization
BioPharm International USA Overview BioPharm International discussed orchestrating the next era of the biopharmaceutical industry through decentralized manufacturing models, automated AAV manufacturing, and modernizing quality control (Q... -
Data Integrity and ALCOA+ Compliance Critical for Bioprocessing Lab Managers: Addressing Regulatory Requirements with Digital Solutions
LabManager.com USA Overview An article highlights the critical importance of data integrity and ALCOA+ compliance for bioprocessing lab managers. Maintaining ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, C... -
Frontiers Develops VR-Based Bioreactor for Biomanufacturing and Environmental Engineering Labs to Enhance Student Proficiency
Frontiers Switzerland Overview Frontiers announced research on the development and piloting of a virtual reality (VR)-based bioreactor for biomanufacturing and environmental engineering labs. This innovative VR system faithfully reproduc... -
Sartorius Unveils Next-Gen Lab Balance ‘Cubis III,’ Enhancing Data Integrity with 21 CFR Part 11 Compliance
Chromatography Online USA Overview Sartorius has launched 'Cubis III,' its latest generation of laboratory balances, offering direct embedded connectivity to digital environments, eliminating the need for middleware and significantly red... -
Benchling Launches ISA-88 Compliant Cloud-Native Bioprocess Platform to Enable High-Throughput Process Development
Benchling USA Overview Benchling has introduced "Benchling Bioprocess," a cloud-native platform featuring an ISA-88 compliant data model to enable high-throughput, structured process development. This integrated environment streamlines p... -
Cellbase Guide: Perfusion Culture Unlocks 10^9 Cells/mL, Revolutionizing Bioreactor Productivity
Cellbase フィンランド Overview Cellbase's new guide on bioreactor scale-up highlights perfusion culture as a critical technology for achieving unprecedented cell densities, often reaching 10^7–10^8 cells/mL and potentially up to 10^9 cel... -
Bispecific Antibody CDMO Market to Surge to $603.13 Billion by 2035, Driven by Diverse Asymmetric Formats
PharmaSource UK Overview This article outlines a market research report from PharmaSource on the bispecific antibody CDMO market, projected to skyrocket from $25.94 billion in 2026 to approximately $603.13 billion by 2035. A key market t... -
EU NK Cell Market Projected for Twofold Growth by 2035, Driven by Increasing Allogeneic NK Cell Therapy Approvals
IndexBox USA Overview This article outlines a report from IndexBox on the European Union's NK cell market, which is expected to double in size between 2026 and 2035. This growth is primarily driven by the approval and commercial launch o... -
Biologics CDMO Market Competitive Landscape Report: Lonza, Samsung Biologics, and WuXi Biologics Drive Growth
National Law Review USA Overview This article summarizes a report on the competitive landscape and growth drivers of the biologics CDMO market. Key players include Lonza Group Ltd, Samsung Biologics Co Ltd, WuXi Biologics Cayman Inc, The...
